Standout Papers

Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer 2016 2026 2019 2022 6.9k
  1. Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer (2016)
    Martin Reck, Delvys Rodríguez‐Abreu et al. New England Journal of Medicine
  2. Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater (2019)
    Martin Reck, Delvys Rodríguez‐Abreu et al. Journal of Clinical Oncology
  3. Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50% (2021)
    Martin Reck, Delvys Rodríguez‐Abreu et al. Journal of Clinical Oncology
  4. A Randomized, Placebo-Controlled Trial of Pembrolizumab Plus Chemotherapy in Patients With Metastatic Squamous NSCLC: Protocol-Specified Final Analysis of KEYNOTE-407 (2020)
    Luis Paz‐Ares, David Vicente et al. Journal of Thoracic Oncology
  5. Pembrolizumab Plus Chemotherapy in Squamous Non–Small-Cell Lung Cancer: 5-Year Update of the Phase III KEYNOTE-407 Study (2023)
    Silvia Novello, Dariusz M. Kowalski et al. Journal of Clinical Oncology

Immediate Impact

3 by Nobel laureates 4 from Science/Nature 73 standout
Sub-graph 1 of 19

Citing Papers

Therapy-induced senescent cancer cells contribute to cancer progression by promoting ribophorin 1-dependent PD-L1 upregulation
2025 Standout
New promises and challenges in the treatment of advanced non-small-cell lung cancer
2024 Standout
30 intermediate papers

Works of Ali Tafreshi being referenced

Pembrolizumab Plus Chemotherapy in Squamous Non–Small-Cell Lung Cancer: 5-Year Update of the Phase III KEYNOTE-407 Study
2023 Standout
Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%
2021 Standout
and 8 more

Author Peers

Author Last Decade Papers Cites
Ali Tafreshi 6016 8696 794 1901 92 11.3k
Marcin Kowanetz 5621 9158 662 2548 106 11.9k
Helen X. Chen 2512 4050 672 716 83 8.7k
Laura Q.M. Chow 4544 8861 1279 2951 156 12.1k
Yves Humblet 5501 12675 2205 790 174 15.6k
Donald P. Lawrence 1709 6555 435 2061 157 8.7k
Vivian Weinberg 3291 2153 2076 952 172 7.6k
Beow Y. Yeap 10059 6993 1270 529 203 14.1k
Emily K. Bergsland 1729 6965 1001 727 198 10.7k
Lars Bastholt 1669 4073 1308 1073 181 8.1k
Ronit Simantov 4224 3293 765 1404 87 11.0k

All Works

Loading papers...

Rankless by CCL
2026